pembrolizumab
merck
['melanoma', 'nsclc', 'sclc', 'pembro']
you want to know what will happen with immunology in early nsclc in the next years? just look at the melanoma track. neoadjuvant pembro outperformed by far adjuvant pembro: hr=0.58 / efs. would not be surprised by similar outcomes with chemo io in resected stage iii nsclc #esmo22 
Medical Oncologist - Lung cancer & thymic tumors. Head of Clinical Research @GustaveRoussy - Head of Scientific Chairs Council @EORTC. Tweets are my own.